1-3 of 3
M. R. Schaafsma, MD PhD
Close
Sort by
Journal Articles

Bortezomib Maintenance Therapy after Induction with R-CHOP, ARA-C and Autologous Stem Cell Transplantation in Newly Diagnosed MCL Patients, Results of a Multicenter Phase II HOVON Study

Jeanette K Doorduijn, MD PhD, Monique C. Minnema, MD PhD, Marie Jose Kersten, MD PhD, Pieternella J Lugtenburg, MD PhD, Martin R. Schipperus, MD PhD, Marinus van Marwijk Kooy, MD PhD, Marius MacKenzie, MD PhD, Josée M Zijlstra, MD, Henriette W Berenschot, MD, M. R Schaafsma, MD PhD, Dana A Chitu, PhD, Hanneke C. Kluin-Nelemans, MD PhD
Journal: Blood
Blood (2015) 126 (23): 339.
https://doi.org/10.1182/blood.V126.23.339.339
Published: 2015
Journal Articles

Thalidomide Combined With High Dose Melphalan Improves Event Free and Overall Survival In Patients With Newly Diagnosed Multiple Myeloma: Extended Follow-Up Of The HOVON-50 Trial

Henk Lokhorst, Bronno van der Holt, PhD, Sonja Zweegman, MD PhD, Edo Vellenga, MD, PhD, Sandra Croockewit, MD, Marinus H.J. Van Oers, MD, PhD, Peter von dem Borne, MD, PhD, Pierre W. Wijermans, MD, PhD, M. R Schaafsma, MD, PhD, Okke de Weerdt, Shulamiet Wittebol, MD, Michel Delforge, MD, PhD, Gerard M.J. Bos, Prof MD PhD, Harm Sinnige, Marinus MarwijkKooy, Peter Joosten, MD, Monique C. Minnema, MD PhD, Rianne Ammerlaan, Pieter Sonneveld, MD, Ph.D
Journal: Blood
Blood (2013) 122 (21): 3332.
https://doi.org/10.1182/blood.V122.21.3332.3332
Published: 2013
Journal Articles

Primary Allogeneic T-Cell Responses Against In Vitro Modified Mantle Cell Lymphoma (MCL) Cells: Implications for Adoptive Immunotherapy after HLA-Matched Stem Cell Transplantation (SCT).

M. Hoogendoorn, MD, J. Olde Wolbers, W. M. Smit, MD PhD, I. Jedema, PhD, M. R. Schaafsma, MD PhD, R. M.Y. Barge, MD PhD, R. Willemze, MD PhD, J. H.F. Falkenburg, MD PhD
Journal: Blood
Blood (2004) 104 (11): 2118.
https://doi.org/10.1182/blood.V104.11.2118.2118
Published: 2004